2Settimana·

Biotech still fit for the future in 2025 ?

1
11 Commenti

immagine del profilo
There is no reason for me to leave $BNTX. The pipeline fits - there will be something to look forward to in 2026...
9
immagine del profilo
@TomTurboInvest So it is better to buy when the price falls or realize losses and expect the boom to come in '26.
immagine del profilo
@opportunity_scout_1182 On the basis of which assumptions did you buy BioNTech, or on the basis of which assumptions are you now thinking about selling?

I hope not on the basis of the screenshot in your post. I don't know this stock market letter provider, but there's nothing in it that hasn't been known for months and priced into the share price.

In the end, you have to decide for yourself. As far as your optimal position size is concerned, I can neither advise you to sell nor to buy in the event of falling prices. For myself and my strategy, I certainly won't be selling at the moment, but if there is another big drop, I would rather buy more. But as I said, I don't know your strategy (trading or B&H or...)

🔮 But I don't have one either, and biotech always carries a risk.
immagine del profilo
In December 2024, I invested in BioNTech because I was betting on the approval of a cancer drug and hoping for short-term profits. After further research, I realized that the company basically has a solid foundation. However, the many negative news stories have increasingly clouded my impression. The screenshot is not the only reason; I don't pay much attention to most share newsletters. I'm just overwhelmed by the situation. But thank you very much anyway. @TomTurboInvest
1
immagine del profilo
@opportunity_scout_1182 Everyone has to go through this at some point😅
Don't get confused by too much information. Focus on the essentials of your approach - the oncology pipeline will give BioNTech a new cash cow! Provided they get the therapies through to approval, but that looks pretty good, but it won't be in the short term.
immagine del profilo
@TomTurboInvest Okay, thank you very much for your help. That gives me a little more confidence in my investment again
2
immagine del profilo
@TomTurboInvest A lot of data is coming this year, but I think we will see what comes out of the key programs this year. BNT327, BNT 122
2
I have a share savings plan at $BNTX. I buy about 0.5 shares per month. It always fluctuates a little, as I invest the roundup at TR in $BNTX.
I am currently up 25%. Based on the pipeline, I think prices of 300-500 euros are possible by 2030. For me the best Biontec value in the medium term. Large pipeline, financially well positioned...
2
immagine del profilo
I have and hold them because I have absolute confidence in the people involved, Sahin and Tureci.
At its core, however, BioNTech is a bet on the pipeline.
immagine del profilo
I am also in and will remain in $BNTX - in my view, there is a good pipeline of further products and a strong financial situation.
immagine del profilo
It's 7.1 and you started investing in Biontech a month ago? :D I think if you get so carried away by news in such a short time that you invest and then immediately think about getting out again, then individual stocks (especially in the biotech sector) are not for you. Quite apart from the fact that there has been no new news about the company since the agreement with Upenn and NIH.
Partecipa alla conversazione